AI assistant
Quanterix Corp — Director's Dealing 2020
Aug 11, 2020
33531_dirs_2020-08-11_2524437d-cc2e-4d37-8d4c-5040b85a1342.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Quanterix Corp (QTRX)
CIK: 0001503274
Period of Report: 2020-08-07
Reporting Person: DEKKERS MARIJN E (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-07 | Common Stock | S | 27619.00 | $32.49 | Disposed | 0.00 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6810.00 | Direct |
Footnotes
F1: Reflects the portion of 117,378 shares of the Issuer's common stock held by Novalis LifeSciences Investments I, L.P. (the "Fund") in which the Reporting Person had a pecuniary interest.
F2: This transaction was executed in multiple trades at prices ranging from $32.3489 to $32.5662. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The Reporting Person had sole voting and investment control over all of the shares owned by the Fund and had a pecuniary interest in 27,619 of the shares.
F4: Includes 2,270 restricted stock units.